According to research conducted by Future Market Insights, the Hydroxyproline market is anticipated to exhibit substantial gains, with the market expanding at around 5.6% CAGR from 2023 to 2033.
| Attributes | Details |
|---|---|
| Market Size 2023 | USD 73.1 Million |
| Market Size 2033 | USD 126.0 Million |
| Value CAGR (2023 to 2033) | 5.6% |
| Collective Value Share: Top 3 Countries (2023E) | 35% to 40% |
Hydroxyproline is a non-essential amino acid that is commonly found in collagen, a structural protein in skin, bones, tendons, and connective tissue. It is known for its role in maintaining the integrity and stability of these tissues. It is produced from the amino acid proline by a post-translational modification that occurs after collagen synthesis.
It is used as Structural support as it helps to give strength and stability to the collagen fibers. It is also utilized in wound healing as collagen plays an important role in the healing of wounds, and hydroxyproline is involved in the process, it helps to promote tissue repair and regeneration, especially in connective tissues. Collagen is important for skin health, and it helps to maintain the elasticity and firmness of the skin.
In the medical industry, the measurement of hydroxyproline levels in the blood or urine can be used as a diagnostic tool for certain medical conditions, such as osteogenesis imperfecta, a genetic disorder that affects the formation of bones.
The thriving demand from the numerous application sections such as pharmaceutical, food, cosmetics, and others will create ample space for the market for flourishing growth during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of Hydroxyproline increased at a CAGR of 4.8% between 2018 and 2022. The growth of the personal care industry across the globe, increasing preferences towards the consumption of dietary fibers, and nutraceuticals, and availability of an improved product that is good for skin as well as for hair, have attributed to the growth of the industry during the historical period.
It is anticipated that the insights revealed by research on the Hydroxyproline market portray substantial gains, with the market expanding at around 5.6% CAGR from 2023 to 2033.
Based on its numerous uses, Hydroxyproline is likely to experience a significant change in the worldwide market, and this trend is predicted to continue during the projection period. The rapid adoption of dietary supplements and substantial demand from the healthcare sector is expected to boost market growth.
Thriving demand from the pharmaceutical industry to boost the sales of Hydroxyproline
Hydroxyproline is manufactured and purified according to strict quality control standards for use in medicinal and pharmaceutical applications. This type of pharmaceutical grade is typically used as an active ingredient in various health supplements and cosmetic products due to its potential benefits for skin health, wound healing, and joint function. It is used as a raw material in the production of anti-aging cosmetic products.
It is also used in some medical treatments, it is used as a marker of collagen content, and is often measured in biopsy samples to diagnose various conditions related to connective tissue metabolisms, such as osteogenesis imperfecta, Ehlers-Danlos syndrome, and osteoporosis. Owing to its use in dietary supplements it is utilized for the treatment of joint pain and osteoarthritis.
Due to its numerous benefits in the pharmaceutical industry, it is anticipated that the market will flourish during the forecast period.
Significant market traction for hydroxyproline for use in cosmetics to propel market growth.
Hydroxyproline in the cosmetic industry is act as a key ingredient in skincare products. It is believed to help boost collagen production and improve the overall health and appearance of the skin. It is often found in anti-aging creams, and moisturizers, and is often marketed as an ingredient that can help reduce the appearance of fine lines and wrinkles.
The rapid growth in the cosmetic industry, owing to the huge demand for the products such as hair conditioners, hair sprays, and skincare products, is anticipated to fuel the global market over the forecast period.
Principal Consultant
By form the Industrial-grade Segment gaining traction in the market, owing to Industrial-grade being a significant form. The segment holds the dominating market share owing to its numerous industrial applications, such as in the production of food additives, production of cosmetics, and pharmaceuticals. It is also used as a raw material in the production of hydroxyproline-containing peptides.
Industrial-grade hydroxyproline typically has a lower level of purity compared to pharmaceutical grade, which is used in medicinal applications. Its use in industrial applications may vary depending on the specific product and industry. Due to significant demand from various end-use sectors, the industrial grade will ramp sales during the forecast period.
Hydroxyproline is used as a nutritional supplement in sports and energy drinks, it is also utilized in food products designed for people with specific dietary needs. It is often added to dietary supplements marketed to improve skin health and reduce signs of aging. There is limited scientific evidence to support these claims, and more research is needed to determine the efficacy of hydroxyproline as a dietary supplement ingredient.
Hydroxyproline has been shown to have antioxidant properties, which makes it a useful ingredient in functional foods marketed for their health benefits. Its use in food is regulated by the FDA and other governing bodies, and it must be declared on the label if it is present in a food product.
The Indian pharmaceutical sector has grown into a booming business and is presently ranked third in the world for pharmaceutical production by volume. According to the Indian Brand Equity Association, India has a significant number of pharmaceutical production facilities that are compliant with the USA Food and Drug Administration (USFDA).
The domestic pharmaceutical industry in India accounts for a network of 3,000 drug companies and approximately 10,500 manufacturing units. India holds a significant place in the global pharmaceuticals sector. The country has a big pool of scientists and engineers that might propel the sector forward to new heights.
It is commonly used in the pharmaceutical industry as an ingredient in the production of drugs and supplements. Owing to its rapid adoption in the pharma industry the market will see traction during the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is fairly consolidated, with tier-one market players owning more than one-third of the overall market share. The Key manufacturers devote a reasonable portion of their earnings to research and development to cut costs, develop new products, and look into new market niches.
To expand their market reach and seize every chance that the industry across various areas has to offer, key manufacturers have shifted their focus to product development.
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.6% from 2023 and 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2023 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million for Value, Volume in Tons, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Form, Application, Region |
| Regions Covered | North America; Latin America; East Asia; South Asia and Pacific; Western Europe; Eastern Europe; Central Asia; Russia and Belarus; Balkan and Baltic Countries; Middle East and Africa |
| Key Countries Covered | The USA, Canada, Mexico, Brazil, Argentina, Germany, France, Spain, Italy, BENELUX, NORDICS, United Kingdom, Poland, Hungary, Romania, Czech Republic, China, Japan, South Korea, India, Association of Southeast Asian Nations, Australia and New Zealand, Kingdom of Saudi Arabia, United Arab Emirates, Türkiye, Northern Africa, South Africa, Israel |
| Key Companies Profiled | HQ Biosciences; KYOWA HKKO USA; AECO CHEM; Shadong Tianmei Biotech Co. Ltd; Henan SenYuan Biological Technology co., Ltd.; Shaanxi Guanjie Technology Co., Ltd; EnColl; Merck Group (Sigma Alrich); Evonik Industries; JINYANG PHARM CO. LTD; Thermo Fisher Scientific Inc.; Zibo Kaimeiyuan Pharmaceutical Technology Co., Ltd; Fengchen Group Co., Ltd |
| Customization and Pricing | Available upon Request |
The market has reported a USD 69.2 Million size in 2022.
The Global market of Hydroxyproline is estimated to reach a valuation of USD 73.1 Million in 2023.
The demand is anticipated to witness a growth rate of 5.6% over the forecast period of 2023 and 2033 in terms of value.
The market is projected to reach USD 126.0 Million by the end of 2033.
The market experienced a value CAGR of 4.8% over the last 4 years.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. By Form 6.2. By Application 7. Global Market Analysis and Forecast, By Form 7.1. Pharmaceutical Grade 7.2. Industrial Grade 8. Global Market Analysis and Forecast, By Application 8.1. Pharmaceutical Intermediate 8.2. Cosmetics 8.3. Food 8.4. Dietary Supplement 8.5. Others 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. South Asia and Pacific 9.6. East Asia 9.7. Central Asia 9.8. Russia and Belarus 9.9. Balkan and Baltic Countries 9.10. Middle East and Africa 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 14. South Asia and Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. Central Asia Sales Analysis and Forecast, by Key Segments and Countries 17. Russia and Belarus Sales Analysis and Forecast, by Key Segments and Countries 18. Balkan and Baltic Countries Sales Analysis and Forecast, by Key Segments and Countries 19. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 20. Sales Forecast by Form and Application for 30 Countries 21. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 22. Company Profile 22.1. HQ Biosciences 22.2. KYOWA HKKO USA 22.3. AECO CHEM 22.4. Shadong Tianmei Biotech Co. Ltd 22.5. Henan SenYuan Biological Technology Co., Ltd. 22.6. Shaanxi Guanjie Technology Co., Ltd 22.7. EnColl 22.8. Merck Group (Sigma Alrich) 22.9. Evonik Industries 22.10. JINYANG PHARM CO. LTD 22.11. Thermo Fisher Scientific Inc. 22.12. Zibo Kaimeiyuan Pharmaceutical Technology Co., Ltd 22.13. Fengchen Group Co., Ltd
Explore Chemicals & Materials Insights
View Reports
Hydroxyproline Market
